UF Health researchers are developing a new generation of tools to monitor diabetes in Florida youths and address disparities in diabetes diagnoses and care.
Todd M. Brusko, associate professor for UF Department of Pathology, Immunology and Laboratory Medicine, has been named Scientific Director of the UF Diabetes Institute (UFDI). Dr. Brusko joins the senior leadership team of the UFDI under its Director, Mark Atkinson, PhD, Pediatric Medical Director, Desmond Schatz, MD, and…
Rohit N. Kulkarni MD, PhD, Professor of Medicine, Harvard Medical School; Margaret A. Congleton Chair and Senior Investigator, Joslin Diabetes Center Seminar Title: “The role of m6A mRNA methylation in regulating beta cell…
Join the Division of Endocrinology, Diabetes, & Metabolism Conferences for a zoom webinar on July 29, 2020 from 3:00 p.m. to 4:00 p.m. *Register to receive Meeting ID & Password via E-mail: https://ufl.zoom.us/meeting/register/tJIvdO2vrDMqH9ZCOb67c0vaASB53LlX1p-I Presented by: Kenneth Cusi MD, FACP, FACE, UFDI Adult Medical Director, Chief, Clinical Professor & VA Faculty in…
Welcome At the University of Florida Diabetes Institute, we are working together for a diabetes-free world.
Medical News Today Article – Expert commentary by nPOD investigators. “The beauty of this approach is the virtual lack of any adverse effects, since it would use the patients’ own cells.” –Prof. Paolo Fiorina…
“We’re building the path to a future without type 1 diabetes.” TrialNet is an international network of leading academic institutions, physicians, scientists and healthcare teams dedicated to the prevention of type 1 diabetes. We offer risk screening for relatives of people with type 1 diabetes and innovative clinical…
As an autoimmune disease, Type 1 diabetes has long been thought to result from a complete immune system killing of the insulin-producing beta cells within the pancreas. Now, University of Florida Health researchers have made a striking discovery: some of the pancreas’ ability to produce insulin may remain for decades…
Common antibiotics do not increase the risk of Type 1 diabetes or celiac disease among children who have a genetic susceptibility for developing those diseases, multinational researchers, including those from the University of Florida, have found. The TEDDY Study Group, which includes University of Florida researcher Eric Triplett,…
